Aimedis is providing an innovative next-generation healthcare solution designed to connect patients to healthcare services and providers like doctors, hospitals and scientific research facilities. While competitors exist in this space, Aimedis is the only operational platform to integrate latest blockchain technology alongside artificial intelligence (AI). Aimedis is the only existing medical ecosystem combining professional healthcare knowledge with the swarm intelligence of patient communities.
Lazaros FountoukidisCMO & MD
Stefan F. KriegPHYSICIST - HPC, DEEP LEARNING & AI
Sebastian WehkampCDO & CREATIVE DIRECTOR
Sopia SingdeeBD ASIA
Yang ChulBOERING PROJECTLEADER CARDIOLOGY & MD
|Token Price||0.12 USD|
|Token for sale||300,000,000 AIM (50%)|
|Token supply||600,000,000 AIM|
|Restricted countries||China, Singapore, United States of America|
|Know Your Customer||Yes|
- Start of development Aimedis 1.0.
- Launch of Aimedis 1.0 in closed environment.
- Getting Certified ISO 9001 & ISO 27001.
- Start of European cooperations SRH hospital group 1.
- ICO white paper release presale in March.
- ICO in April.
- iOS & Android Apps.
- Start of Asian cooperation program.
- Launch of Aimedis 2.0.
- Incetivised patient AIMSocial platform.
- AIMedisafe secure pharma label.
- AIMedisafe backed online drugstore.
- Release of Aimedis 3.0 with AI backed diagnosis & therapy program.
|Whitelist/KYC||Whitelist & KYC|
|Token price||0.12 USD|
|Alexa rank||404,764 th|
|Promotional video views||12,728|
TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.